- Home
- EVOK vs ATNF Comparison
EVOK vs ATNF Comparison
Compare EVOK & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- ATNF
- Stock Information
- Founded
- EVOK 2007
- ATNF 2016
- Country
- EVOK United States
- ATNF United States
- Employees
- EVOK N/A
- ATNF N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- EVOK Health Care
- ATNF Health Care
- Exchange
- EVOK Nasdaq
- ATNF Nasdaq
- Market Cap
- EVOK 4.2M
- ATNF 4.1M
- IPO Year
- EVOK 2013
- ATNF N/A
- Fundamental
- Price
- EVOK $2.59
- ATNF $0.86
- Analyst Decision
- EVOK
- ATNF
- Analyst Count
- EVOK 0
- ATNF 0
- Target Price
- EVOK N/A
- ATNF N/A
- AVG Volume (30 Days)
- EVOK 16.5K
- ATNF 136.6K
- Earning Date
- EVOK 05-13-2025
- ATNF 05-14-2025
- Dividend Yield
- EVOK N/A
- ATNF N/A
- EPS Growth
- EVOK N/A
- ATNF N/A
- EPS
- EVOK N/A
- ATNF N/A
- Revenue
- EVOK $10,249,415.00
- ATNF N/A
- Revenue This Year
- EVOK $58.84
- ATNF N/A
- Revenue Next Year
- EVOK $58.11
- ATNF N/A
- P/E Ratio
- EVOK N/A
- ATNF N/A
- Revenue Growth
- EVOK 97.84
- ATNF N/A
- 52 Week Low
- EVOK $1.94
- ATNF $0.66
- 52 Week High
- EVOK $12.32
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- EVOK 47.70
- ATNF 41.22
- Support Level
- EVOK $2.02
- ATNF $0.80
- Resistance Level
- EVOK $2.53
- ATNF $0.94
- Average True Range (ATR)
- EVOK 0.22
- ATNF 0.11
- MACD
- EVOK 0.10
- ATNF 0.02
- Stochastic Oscillator
- EVOK 97.01
- ATNF 42.78
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.